BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21857811)

  • 1. Changes in drug utilization during a gap in insurance coverage: an examination of the medicare Part D coverage gap.
    Polinski JM; Shrank WH; Huskamp HA; Glynn RJ; Liberman JN; Schneeweiss S
    PLoS Med; 2011 Aug; 8(8):e1001075. PubMed ID: 21857811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficiaries with cardiovascular disease and thePart D coverage gap.
    Polinski JM; Shrank WH; Glynn RJ; Huskamp HA; Roebuck MC; Schneeweiss S
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):387-95. PubMed ID: 22511746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the Part D coverage gap and adverse health outcomes.
    Polinski JM; Shrank WH; Glynn RJ; Huskamp HA; Christopher Roebuck M; Schneeweiss S
    J Am Geriatr Soc; 2012 Aug; 60(8):1408-17. PubMed ID: 22788544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
    Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
    Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis.
    Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
    J Manag Care Spec Pharm; 2015 Oct; 21(10):956-64. PubMed ID: 26402394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment.
    Polinski JM; Schneeweiss S; Glynn RJ; Lii J; Rassen JA
    Pharmacoepidemiol Drug Saf; 2012 May; 21 Suppl 2(Suppl 2):90-8. PubMed ID: 22552984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Medicare Part D on drug and medical spending.
    Zhang Y; Donohue JM; Lave JR; O'Donnell G; Newhouse JP
    N Engl J Med; 2009 Jul; 361(1):52-61. PubMed ID: 19571283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Part D coverage gap reform: trends in drug use and expenditures.
    Park J; Look KA
    Am J Manag Care; 2020 Aug; 26(8):349-356. PubMed ID: 32835462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs.
    Hsu J; Fung V; Price M; Huang J; Brand R; Hui R; Fireman B; Newhouse JP
    JAMA; 2008 Apr; 299(16):1929-36. PubMed ID: 18430912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act.
    Bonakdar Tehrani A; Cunningham PJ
    Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.
    Fung V; Mangione CM; Huang J; Turk N; Quiter ES; Schmittdiel JA; Hsu J
    Health Serv Res; 2010 Apr; 45(2):355-75. PubMed ID: 20050931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures.
    Ettner SL; Steers WN; Turk N; Quiter ES; Mangione CM
    J Gen Intern Med; 2011 Oct; 26(10):1195-200. PubMed ID: 21710313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
    Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
    Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demand for prescription drugs under non-linear pricing in Medicare Part D.
    Jung K; Feldman R; McBean AM
    Int J Health Care Finance Econ; 2014 Mar; 14(1):19-40. PubMed ID: 24214101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.
    McWilliams JM; Zaslavsky AM; Huskamp HA
    JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.